NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that it will appoint Erin L. Russell, a financial and ...

Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) has received a consensus rating of “Reduce” from the twelve analysts that are currently covering the stock, MarketBeat Ratings reports.

Fortrea Holdings Inc., a prominent player in the U.S. Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by divergent trends across its key ...

Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Fortrea met analysts’ revenue expectations ...

On Monday, TD Cowen's analysts revised their outlook for Fortrea (NASDAQ: FTRE), a company operating in the contract research organization (CRO) industry. The firm's price target for Fortrea ...

Fortrea has a fifty-two week low of $13.48 and a fifty-two week high of $41.02. In other news, CEO Thomas Pike sold 11,268 shares of the stock in a transaction on Monday, January 13th. The stock ...

Fortrea Holdings Inc., a prominent player in the U.S. Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by divergent trends across its key business ...

Fortrea, a global contract research organization, has announced its sponsorship of the Society for Clinical Research Sites' (SCRS) Collaborate Forward working group, consisting of 16 Global Impact ...